in this issue
Regions :: Western Europe :: Germany
Bayer appoints board member responsible for innovation
December 19, 2013 | Deepti Ramesh
Bayer says that its supervisory board has appointed Kemal Malik to its board of management, effective 1 February 2014. Malik has been a member of the Bayer HealthCare executive committee, head/global development, and chief medical officer since 2007. He is to succeed Wolfgang Plischke upon the latter's retirement on 30 April 2014. Plischke joined Bayer in 1980 and has been a member of the board of management since March 2006. He is responsible for innovation, technology, sustainability, and Asia/Pacific. Malik will be responsible for innovation and take over...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee